CITO liquid biopsy analysis for cancer treatment
Medical device
CITO is a rapid liquid biopsy diagnostics platform that improves patient experience in cancer care. The platform makes it possible for non-specialist technicians in small clinics to monitor patient response to treatment while a patient waits, significantly reducing delays to diagnostic results. The compact device combines functions of three instruments in an easy-to-sterilise form and sub-surface lighting pulses intuitively to alert system status. CITO opens the door to personalised cancer treatment by giving oncologists rapid access to biopsy data so they can make informed adjustments to each patient's treatment plan.
Development Time
up to 12 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Trade / Industry, Other target groups: Healthcare professionals